Spots Global Cancer Trial Database for bioequivalence

Every month we try and update this database with for bioequivalence cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
A Study to Assess the Relative Bioavailability of Process Variants of Selumetinib in Healthy Male Volunteers	NCT02322749	Healthy Volunte...	selumetinib 75m... selumetinib 75m... selumetinib 75m...	18 Years - 45 Years	AstraZeneca
A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors	NCT00046111	Lung Cancer, Sm... Solid Tumor Can...	topotecan	18 Years -	GlaxoSmithKline
A Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection	NCT04460820	Bioequivalence	Doxorubicin Hyd...	18 Years - 75 Years	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis	NCT00948428	Actinic Keratos...	imiquimod Aldara™ Vehicle Cream	18 Years -	Actavis Inc.
Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System	NCT02343081	Brain Neoplasms...	Temozolomide Temozolomide	21 Years -	Monte Verde SA
A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjects With Ovarian Cancer	NCT03400306	Cancer - Ovaria...	Veliparib, caps... Veliparib, tabl... Carboplatin Paclitaxel	18 Years - 99 Years	AbbVie
Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer	NCT02064829	Metastatic Brea... Locally Recurre...	Nab-paclitaxel IG-001	30 Years -	Sorrento Therapeutics, Inc.
Bioequivalence Study of Azacitidine for Injection in Myelodysplastic Syndrome (MDS) Patients	NCT01152346	Myelodysplastic...	Azacitidine for... Vidaza®	18 Years -	Bioniche Pharma USA LLC
A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01)	NCT02031991	Healthy	PF-06439535 Avastin Avastin	21 Years - 55 Years	Pfizer
A Bioequivalence Study of Docetaxel Injection in Patients With Solid Tumours	NCT04889599	Docetaxel Solid Tumours Bioequivalence	BH009 (Docetaxe... Docetaxel injec...	18 Years -	Zhuhai Beihai Biotech Co., Ltd
Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System	NCT02343081	Brain Neoplasms...	Temozolomide Temozolomide	21 Years -	Monte Verde SA
A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjects With Ovarian Cancer	NCT03400306	Cancer - Ovaria...	Veliparib, caps... Veliparib, tabl... Carboplatin Paclitaxel	18 Years - 99 Years	AbbVie
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors	NCT04672460	Advanced Solid ... Solid Tumors Ovarian Cancer Breast Cancer Prostate Cancer NSCLC Pancreatic Canc... Colorectal Canc...	TALZENNA capsul... Talazoparib sof... Talazoparib sof...	18 Years - 70 Years	Pfizer
Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients With Colorectal or Breast Cancer	NCT04420871	Patient Partici...	150 mg of Xelod... 150 mg of capec...	28 Years - 69 Years	The Affiliated Hospital of Qingdao University
A Pharmacokinetic Study Comparing PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-01)	NCT01603264	Healthy	PF-05280014 Herceptin Herceptin	18 Years - 55 Years	Pfizer
Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment	NCT04256707	Non-Small Cell ... Colorectal Canc... Other Solid Tum...	Selinexor 100 m... Docetaxel Pembrolizumab FOLFIRI Selinexor 40 mg Selinexor 80 mg Selinexor 60 mg	18 Years -	Karyopharm Therapeutics Inc
A Study to Assess the Relative Bioavailability of Process Variants of Selumetinib in Healthy Male Volunteers	NCT02322749	Healthy Volunte...	selumetinib 75m... selumetinib 75m... selumetinib 75m...	18 Years - 45 Years	AstraZeneca
A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations	NCT03082300	Non-small Cell ... Epidermal Growt...	naquotinib	18 Years -	Astellas Pharma Inc
Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors	NCT01421004	Advanced Solid ... Excluding Breas...	TKI258	18 Years -	Novartis
Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer	NCT02064829	Metastatic Brea... Locally Recurre...	Nab-paclitaxel IG-001	30 Years -	Sorrento Therapeutics, Inc.
Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors	NCT01421004	Advanced Solid ... Excluding Breas...	TKI258	18 Years -	Novartis
Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis	NCT00948428	Actinic Keratos...	imiquimod Aldara™ Vehicle Cream	18 Years -	Actavis Inc.
Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System	NCT02343081	Brain Neoplasms...	Temozolomide Temozolomide	21 Years -	Monte Verde SA
Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors	NCT01421004	Advanced Solid ... Excluding Breas...	TKI258	18 Years -	Novartis

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: